Relative risks of death within 5 years of diagnosis for men versus women stratified by histology, stage, age groups and diagnostic periods
| Females (n=13 983) | Males (n=25 721) | p Value | |
| HR 95% CI | HR 95% CI | ||
| Histology | |||
| (adjusted for stage, age and diagnostic period) | |||
| Adenocarcinoma | 1.000 | 1.244 (1.191 to 1.298) | <0.001 |
| NOS | 1.000 | 1.141 (1.078 to 1.207) | <0.001 |
| Squamous cell carcinoma | 1.000 | 1.048 (0.994 to 1.105) | 0.084 |
| Small cell carcinoma | 1.000 | 1.052 (1.001 to 1.105) | 0.045 |
| Large cell carcinoma | 1.000 | 1.147 (1.033 to 1.273) | 0.010 |
| Stage | |||
| (adjusted for histology, age and diagnostic period) | |||
| Localised disease | 1.000 | 1.252 (1.179 to 1.330) | <0.001 |
| Regional disease | 1.000 | 1.112 (1.059 to 1.168) | <0.001 |
| Metastatic disease | 1.000 | 1.103 (1.066 to 1.141) | <0.001 |
| Unknown | 1.000 | 1.135 (1.045 to 1.233) | 0.003 |
| Age (years) | |||
| (adjusted for histology, stage and diagnostic period) | |||
| 0–49 | 1.000 | 1.169 (1.053 to 1.298) | 0.003 |
| 50–59 | 1.000 | 1.185 (1.117 to 1.257) | <0.001 |
| 60–69 | 1.000 | 1.169 (1.119 to 1.220) | <0.001 |
| 70–79 | 1.000 | 1.108 (1.064 to 1.154) | <0.001 |
| 80 and over | 1.000 | 1.095 (1.017 to 1.179) | 0.016 |
| Diagnostic period | |||
| (adjusted for histology, stage and age) | |||
| 1988–1992 | 1.000 | 1.100 (1.042 to 1.162) | 0.001 |
| 1993–1997 | 1.000 | 1.137 (1.081 to 1.196) | <0.001 |
| 1998–2002 | 1.000 | 1.163 (1.110 to 1.218) | <0.001 |
| 2003–2007 | 1.000 | 1.125 (1.076 to 1.175) | <0.001 |
NOS, not otherwise specifed.